Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00767026 · ClinicalTrials.gov registry record · Phase 1

COPE Intervention for Parents of Children With Epilepsy

A Phase 1 study of Epilepsy, sponsored by Boston Children's Hospital.

Completed
Registry status
Phase 1
Development phase
88
Enrollment target
1
Study location

NCT00767026: Completed Phase 1 study of Epilepsy, sponsored by Boston Children's Hospital.

NCT00767026 is a Phase 1 study of Epilepsy that has completed, run by Boston Children's Hospital. The registered enrollment target is 88 participants, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00767026, a Phase 1 study of Epilepsy, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
Phase 1
Development phase
88 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine if the program Creating Opportunities for Parent Empowerment (COPE) is feasible to administer to parents of children with neurological conditions. The goal of the study is to empower parents by providing them with educational materials designed to teach them how to foster healthy coping skills in their child.

Conditions Studied

Interventions

  • BEHAVIORAL Standard education
  • BEHAVIORAL COPE (Creating Opportunities for Parent Empowerment)

Study Locations (1)

Massachusetts

  • Children's Hospital Boston - Boston

Trial Details

FieldValue
Enrollment Target 88 participants
Start Date 2008-01
Est. Completion 2010-12
Phase Phase 1
Boston Children's Hospital

462 total trials

What the finished NCT00767026 record still lists

NCT00767026 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 88 participants, a relatively small participant target, below the 952-participant average among 160 other Epilepsy trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Epilepsy appearing as the primary indexed condition, and to 2 interventions - of which Standard education is the first listed.

NCT00767026 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT00767026 about?

NCT00767026 is a clinical study titled "COPE Intervention for Parents of Children With Epilepsy". The purpose of this study is to determine if the program Creating Opportunities for Parent Empowerment (COPE) is feasible to administer to parents of children with neurological conditions. The goal of the study is to empower parents by providing them with educational materials designed to teach them...

What is the current status of trial NCT00767026?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 88 participants. The study started on 2008-01. Estimated completion is 2010-12.

What conditions does trial NCT00767026 study?

This clinical trial studies the following conditions: Epilepsy.

What interventions are being tested in trial NCT00767026?

The interventions under investigation include: Standard education (BEHAVIORAL), COPE (Creating Opportunities for Parent Empowerment) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00767026?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00767026 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Epilepsy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00767026's enrollment target sits among peer trials

88 63rd of 160 higher than 98 of 160 other Epilepsy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03843463 · 88 participants · Phase 2

    Escitalopram and Language Intervention for Subacute Aphasia

  • NCT04066348 · 88 participants · Phase 2

    TNF-α Treatment of Blast-Induced Tinnitus

  • NCT04331704 · 88 participants · Phase 4

    ANCHORS Alcohol & Sexual Health Study: UH3 Project

  • NCT04536103 · 88 participants

    Multi-Vendor Multi-Site Novel Accelerated MRI Relaxometry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00767026, the US trial registry maintained by the National Library of Medicine. NCT00767026 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.